Skip to main content
SpringerLink
Log in

Psoriatic Arthritis

  • Chapter
Psoriasis and Psoriatic Arthritis

  • 1333 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 140: 659–662

    Google Scholar 

  2. Clegg DO, Reda DJ, Mejias E, Cannon GW, Weisman MH, Taylor T, et al. (1996) Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39: 2013–2020

    PubMed  CAS  Google Scholar 

  3. Kaltwasser J, Nash P, Gladman D, Rosen C, Behrens F, Mease P (2003) Leflunomide in the treatment of psoriatic arthritis and psoriasis: data from a double-blind, randomized, placebo-controlled clinical trial. Ann Rheum Dis 62(Suppl 1): abstract no.OP0081

    Google Scholar 

  4. Mease P, Kivitz A, Burch F, Siegel E, Cohen S, Burge D (2001) Improvement in disease activity in patients with psoriatic arthritis receiving etanercept (Enbrel): results of a phase 3 multicenter clinical trial [abstract]. Arthritis Rheum 44(Suppl 9): S90

    Google Scholar 

  5. Antoni C, Kavanaugh A, Kirkham B, Burmester G, Weisman M, Keystone E, et al. (2002) The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT) [abstract]. Arthritis Rheum 46(Suppl 9): S381

    Google Scholar 

  6. Antoni CE, Kavanaugh A, Kirkham B, Burmester G, Manger B, Tutuncu Z, et al. (2003) The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): Substantial Efficacy on Synovitis and Psoriatic Lesions With or Without DMARD Therapy. Ann Rheum Dis 62(Suppl 1): abstract no. OP0082

    Google Scholar 

  7. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. (1995) American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38: 727–735

    PubMed  CAS  Google Scholar 

  8. van Gestel AM, Prevoo ML, van’t Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL (1996) Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 39: 34–40

    PubMed  Google Scholar 

  9. Piet LCM, van Gestel AM, Scott DL (2000) EULAR Handbook of Clinical Assessments in Rheumatoid Arthritis. Van Zuiden Communications BV, Alphen aan den Rijn, The Netherlands

    Google Scholar 

  10. Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38: 44–48

    PubMed  CAS  Google Scholar 

  11. Paulus HE, Ramos B, Wong WK, Ahmed A, Bulpitt K, Park G, et al. (1999) Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists. J Rheumatol 26: 2324–2331

    PubMed  CAS  Google Scholar 

  12. Fransen J, Welsing PMJ, De Keijzer RMH, Van Riel PLCM (2003) Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis 62(Suppl 1): abstract no. THU0138

    Google Scholar 

  13. van Gestel AM, Anderson JJ, van Riel PL, Boers M, Haagsma CJ, Rich B, et al. (1999) ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. J Rheumatol 26: 705–711

    PubMed  Google Scholar 

  14. Ujfalussy I, Koo E (2003) Measurement of disease activity in psoriatic arthritis. Extended report. Z Rheumatol 62: 60–65

    PubMed  CAS  Google Scholar 

  15. Gladman DD, Helliwell P, Mease PJ, Nash P, Ritchlin C, Taylor W (2004) Assessment of patients with psoriatic arthritis: a review of currently available measures. Arthritis Rheum 50: 24–35

    Article  PubMed  Google Scholar 

  16. Gladman DD, Hing EN, Schentag CT, Cook RJ (2001) Remission in psoriatic arthritis. J Rheumatol 28: 1045–1048

    PubMed  CAS  Google Scholar 

  17. Prevoo ML, van Gestel AM, van THMA, van Rijswijk MH, van de Putte LB, van Riel PL (1996) Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 35: 1101–1105

    Article  PubMed  CAS  Google Scholar 

  18. Gladman DD, Farewell V, Buskila D, Goodman R, Hamilton L, Langevitz P, et al. (1990) Reliability of measurements of active and damaged joints in psoriatic arthritis. J Rheumatol 17: 62–64

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology & Medicine, Hospital for Joint Diseases, New York, NY, USA

    Soumya M. Reddy MD

  2. Johns Hopkins University, Baltimore, MD, USA

    Clifton O. Bingham III MD

Authors
  1. Soumya M. Reddy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clifton O. Bingham III MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Dermatology, Loyola University, Stritch School of Medicine, 2160 S. First Ave., Building 112, Room 342, Maywood, IL, 60153, USA

    Kenneth B. Gordon MD

  2. Division of Rheumatology, Northwestern University, Feinberg School of Medicine, 675 N. St. Clair St., Chicago, IL, 60611, USA

    Eric M. Ruderman MD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Reddy, S.M., Bingham, C.O. (2005). Psoriatic Arthritis. In: Gordon, K.B., Ruderman, E.M. (eds) Psoriasis and Psoriatic Arthritis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27190-2_15

Download citation

  • DOI: https://doi.org/10.1007/3-540-27190-2_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21280-5

  • Online ISBN: 978-3-540-27190-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation